Mineralocorticoid Antagonism and Diabetic Kidney Disease

被引：0
|
作者：
Yuliya Lytvyn
Lucas C. Godoy
Rosalie A. Scholtes
Daniël H. van Raalte
David Z. Cherney
机构：
[1] UHN,Toronto General Hospital Research Institute
[2] University of Toronto,Peter Munk Cardiac Centre
[3] Universidade de Sao Paulo,Instituto do Coracao (InCor), Faculdade de Medicina FMUSP
[4] Amsterdam University Medical Center,Diabetes Center, Department of Internal Medicine
[5] location VU University Medical Center,Department of Medicine, Division of Nephrology, University Health Network
[6] University of Toronto,Department of Physiology
[7] Banting and Best Diabetes Centre,undefined
[8] University of Toronto,undefined
来源：
Current Diabetes Reports | 2019年 / 19卷
关键词：
Mineralocorticoid receptor antagonist; Diabetes; Diabetic kidney disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Mineralocorticoid Antagonism and Diabetic Kidney Disease
    Lytvyn, Yuliya
    Godoy, Lucas C.
    Scholtes, Rosalie A.
    van Raalte, Daniel H.
    Cherney, David Z.
    [J]. CURRENT DIABETES REPORTS, 2019, 19 (01)
  • [2] Perspective on Nonsteroidal Mineralocorticoid Receptor Antagonism in Diabetic Kidney Disease
    Ghuman, Jasleen K.
    Tuttle, Katherine R.
    [J]. KIDNEY360, 2022, 3 (04): : 744 - 748
  • [3] Impact of Mineralocorticoid Receptor Antagonism in a New Model of Diabetic Kidney Disease
    Ramirez, Roberto Palacios
    Posada, Ixchel Q. Lima
    Bonnard, Benjamin
    Genty, Marie
    Hartleib-Geschwindner, Judith
    Foufelle, Fabienne
    Bamberg, Krister
    Jaisser, Frederic
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 240 - 240
  • [4] Mineralocorticoid Receptor Antagonism in Chronic Kidney Disease
    Georgianos, Panagiotis I.
    Agarwal, Rajiv
    [J]. KIDNEY INTERNATIONAL REPORTS, 2021, 6 (09): : 2281 - 2291
  • [5] MINERALOCORTICOID RECEPTOR ANTAGONISM IN CHRONIC KIDNEY DISEASE
    Gillis, Keith
    Lees, Jennifer
    Jardine, Alan
    Traynor, Jamie
    Mark, Patrick
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 468 - 469
  • [6] Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study
    Kovarik, Johannes J.
    Kaltenecker, Christopher C.
    Domenig, Oliver
    Antlanger, Marlies
    Poglitsch, Marko
    Kopecky, Chantal
    Saemann, Marcus D.
    [J]. DIABETES THERAPY, 2021, 12 (09) : 2485 - 2498
  • [7] Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study
    Johannes J. Kovarik
    Christopher C. Kaltenecker
    Oliver Domenig
    Marlies Antlanger
    Marko Poglitsch
    Chantal Kopecky
    Marcus D. Säemann
    [J]. Diabetes Therapy, 2021, 12 : 2485 - 2498
  • [8] Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
    Kawanami, Daiji
    Takashi, Yuichi
    Muta, Yoshimi
    Oda, Naoki
    Nagata, Dai
    Takahashi, Hiroyuki
    Tanabe, Makito
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [9] Mineralocorticoid Receptor Antagonists for Diabetic Kidney Disease
    Rossing, Peter
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (12): : 1696 - 1698
  • [10] Nonsteroidal mineralocorticoid antagonists in diabetic kidney disease
    Dojki, Farheen K.
    Bakris, George
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2017, 26 (05): : 368 - 374
12345